scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0006-2952(98)00099-9 |
P698 | PubMed publication ID | 9698092 |
P2093 | author name string | Chen Y | |
Wu H | |||
Kang YJ | |||
Yin X | |||
P2860 | cites work | Genomic sequencing | Q24594942 |
Measurement of protein using bicinchoninic acid | Q26778491 | ||
Risk factors for doxorubicin-induced congestive heart failure | Q28328220 | ||
Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity | Q28379102 | ||
Catalase in vitro | Q29615710 | ||
Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro | Q33614685 | ||
Adriamycin. A new anticancer drug with significant clinical activity | Q34699440 | ||
Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin | Q34718010 | ||
Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity | Q37949829 | ||
Transcriptional induction of the mouse metallothionein-I gene in hydrogen peroxide-treated Hepa cells involves a composite major late transcription factor/antioxidant response element and metal response promoter elements | Q40231950 | ||
Oxygen free radicals and metallothionein | Q40889930 | ||
Cd2+-induced synthesis of metallothionein in HeLa cells | Q42166080 | ||
Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol. | Q52389045 | ||
Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine | Q54275536 | ||
Effect of adriamycin on the activities of superoxide dismutase, glutathione peroxidase and catalase in tissues of mice. | Q55001119 | ||
Specific reduction of toxic side effects of adriamycin by induction of metallothionein in mice. | Q55039832 | ||
Effect of adriamycin on DNA, RNA and protein biosyntheses in mouse tissues, in connection with its cardiotoxicity. | Q55331812 | ||
Free radical production from normal and adriamycin-treated rat cardiac sarcosomes | Q60786740 | ||
Glutathione peroxidase activity and selenium concentration in the hearts of doxorubicin-treated rabbits | Q67419114 | ||
Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response | Q67590955 | ||
Selective alterations in rat cardiac mRNA induced by doxorubicin: Possible subcellular mechanisms | Q67689543 | ||
13 Determination of metallothionein in tissues by cadmium-hemoglobin affinity assay | Q67836399 | ||
Increase in metallothionein produced by chemicals that induce oxidative stress | Q67972792 | ||
Metallothionein induction prevents toxic side effects of cisplatin and adriamycin used in combination | Q68286163 | ||
Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues | Q68732983 | ||
Glutathione biosynthesis; gamma-glutamylcysteine synthetase from rat kidney | Q69876469 | ||
The role of lipid peroxidation in acute doxorubicin-induced cardiotoxicity as studied in rat isolated heart | Q69882031 | ||
Glutathione reductase | Q70123854 | ||
An electron spin resonance study of the reduction of peroxides by anthracycline semiquinones | Q70217290 | ||
Effects of multiple doxorubicin doses on mouse cardiac and hepatic catalase | Q70685435 | ||
Decrease of myocardial mRNA in adriamycin‐treated rats | Q70760493 | ||
Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice | Q71119918 | ||
Assays of glutathione peroxidase | Q71365824 | ||
Does catalase play a role in adriamycin induced cardiotoxicity? | Q71413856 | ||
Adriamycin-induced hepatic and myocardial lipid peroxidation and DNA damage, and enhanced excretion of urinary lipid metabolites in rats | Q72418062 | ||
Modulation of glutathione and glutathione dependent antioxidant enzymes in mouse heart following doxorubicin therapy | Q72567090 | ||
Effect of adriamycin on the polyribosome and messenger-RNA content of rat heart muscle | Q72613226 | ||
Effects of adriamycin on heart and skeletal muscle chromatin | Q72667168 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | doxorubicin | Q18936 |
P304 | page(s) | 87-93 | |
P577 | publication date | 1998-07-01 | |
P1433 | published in | Biochemical Pharmacology | Q864229 |
P1476 | title | Induction of antioxidants by adriamycin in mouse heart | |
P478 | volume | 56 |
Q35566390 | A metabolomic study of rats with doxorubicin-induced cardiomyopathy and Shengmai injection treatment |
Q46062368 | ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat. |
Q87515402 | Amelioration of adriamycin-induced cardiotoxicity by Salsola kali aqueous extract is mediated by lowering oxidative stress |
Q43839992 | Attenuation of the acute adriamycin-induced cardiac and hepatic oxidative toxicity by N-(2-mercaptopropionyl) glycine in rats |
Q33777922 | Biologic and pharmacologic regulation of mammalian glutathione synthesis |
Q44590151 | Captopril and enalaprilat decrease antioxidant defences in human endothelial cells and are unable to protect against apoptosis |
Q35084851 | Cardiac metallothionein synthesis in streptozotocin-induced diabetic mice, and its protection against diabetes-induced cardiac injury |
Q32078137 | Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat. |
Q43615200 | Doxorubicin-induced persistent oxidative stress to cardiac myocytes. |
Q44005838 | Early changes in myocardial antioxidant enzymes in rats treated with adriamycin |
Q52073405 | Effect of Adriamycin on the boundary lipid structure of cytochrome c oxidase: pico-second time-resolved fluorescence depolarization studies. |
Q42872456 | Fullerenol C60(OH)24 prevents doxorubicin-induced acute cardiotoxicity in rats. |
Q46402238 | Fullerenol nanoparticles prevents doxorubicin-induced acute hepatotoxicity in rats |
Q44120572 | Induction of metallothionein by zinc protects from daunorubicin toxicity in rats |
Q37913211 | Mammalian metallothionein in toxicology, cancer, and cancer chemotherapy |
Q44558496 | Melatonin stimulates the activity of protective antioxidative enzymes in myocardial cells of rats in the course of doxorubicin intoxication |
Q57808244 | Metallothionein and Superoxide Dismutase-Antioxidative Protein Status in Fullerene-Doxorubicin Delivery to MCF-7 Human Breast Cancer Cells |
Q85637911 | Molecular mechanisms by which white tea prevents oxidative stress |
Q43825116 | Potential protective role of angiotensin-converting enzyme inhibitors captopril and enalapril against adriamycin-induced acute cardiac and hepatic toxicity in rats |
Q44955455 | Prevention of acute adriamycin cardiotoxicity by dantrolene in rats |
Q44961507 | Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4. |
Q47344811 | Protective effects of 'Khamira Abresham Hakim Arshad Wala', a unani formulation against doxorubicin-induced cardiotoxicity and nephrotoxicity. |
Q44458679 | Protective role of DLalpha-lipoic acid against adriamycin-induced cardiac lipid peroxidation |
Q33878163 | Regulation of gamma-glutamylcysteine synthetase subunit gene expression: insights into transcriptional control of antioxidant defenses |
Q39157106 | Role of ATP as a Key Signaling Molecule Mediating Radiation-Induced Biological Effects |
Q44202906 | Simultaneous angiotensin converting enzyme inhibition moderates ventricular dysfunction caused by doxorubicin |
Q26824041 | Zinc and the prooxidant heart failure phenotype |